palmitic acid has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| André, A; Clouet, P; Degrace, P; Demaison, L; Demizieux, L; Gresti, J; Tsoko, M | 1 |
| Braam, B; Verhaar, MC | 1 |
1 review(s) available for palmitic acid and cardiovascular agents
| Article | Year |
|---|---|
Understanding eNOS for pharmacological modulation of endothelial function: a translational view.
Topics: Animals; Atherosclerosis; Cardiovascular Agents; Cardiovascular Diseases; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Guanylate Cyclase; Humans; Kidney Diseases, Cystic; Myristic Acid; Nitric Oxide; Nitric Oxide Synthase Type III; Palmitic Acid; Phosphorylation; Protein Processing, Post-Translational; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Risk Factors; Signal Transduction; Soluble Guanylyl Cyclase | 2007 |
1 other study(ies) available for palmitic acid and cardiovascular agents
| Article | Year |
|---|---|
Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat.
Topics: Animals; Biological Transport; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Esterification; Fatty Acids; Gene Expression Regulation; In Vitro Techniques; Lipoprotein Lipase; Male; Methylhydrazines; Mitochondria, Heart; Myocardium; Oxidation-Reduction; Oxygen Consumption; Palmitic Acid; Perfusion; Rats; Rats, Wistar; RNA, Messenger; Triglycerides | 2004 |